About Prime Medicine, Inc. (adapted from Prime Medicine, Inc. prospectus):
They are a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, Prime Editors, to address the widest spectrum of diseases by deploying their Prime Editing technology, which they believe is a versatile, precise, efficient and broad gene editing technology.

This description is adapted from Prime Medicines, Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.